Reviva pharmaceuticals holdings, inc. reports second quarter 2021 financial results and recent business highlights

-closed underwritten public offering of common stock and warrants resulting in gross proceeds of $34.5 million
RVPH Ratings Summary
RVPH Quant Ranking